Shares of Cipher Pharmaceuticals Inc. (TSE:CPH – Get Rating) (NASDAQ:CPHR) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$3.19 and traded as high as C$3.45. Cipher Pharmaceuticals shares last traded at C$3.45, with a volume of 12,267 shares changing hands.
Cipher Pharmaceuticals Stock Performance
The firm’s 50-day moving average is C$3.19 and its 200 day moving average is C$2.64. The stock has a market cap of C$86.65 million and a PE ratio of 8.63. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.67 and a current ratio of 2.87.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug.
- International Game Technology is Well Worth the Gamble
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Use The Airbnb Stock Implosion to Your Advantage
- Why Lowe’s Is Up And Home Depot Down
- The TJX Companies Could Break Out To New Highs
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.